Roth Capital upgrades shares to Buyfrom Neutral with a $25 price target, seeing potential for the stock to "leap higher on any healthy amount of good news such as reinstating guidance and margin stability."
https://seekingalpha.com/news/3728311-array-upped-to-buy-at-roth-capital-ahead-of-potential-positive-catalysts